House
RoundsGuidelinesCalculatorsPricing
Sign inCreate account→
House

Citation-backed clinical intelligence for verified physicians.

Product

  • Rounds
  • Guidelines
  • Calculators
  • Pricing

Company

  • About
  • Editorial Policy

© 2026 House

For verified, licensed physicians. Not a substitute for clinical judgement.

Back to guidelines
Nephrology · KDIGO

Acute kidney injury

KDIGO
A
Source:KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury (current2024 KDIGO CKD update for ongoing CKD-AKI overlap)
Verified Apr 2026
Ask House about this guideline

Red Flags

  • Severe AKI with oliguria + hyperkalaemia (K+ ≥6.5 with ECG changes) or refractory acidosis or fluid overload — emergency RRT (haemodialysis or CRRT)[1]
  • AKI with rhabdomyolysis (CK ≥5000) — aggressive IV crystalloid; monitor compartments; alkalinise if clinically indicated[1]
  • Sudden anuria with palpable bladder or hydronephrosis on bedside scan — post-renal obstruction; urgent catheter or nephrostomy[1]
  • Drug-induced AKI from nephrotoxin (NSAIDs, aminoglycosides, vancomycin, contrast, ACE-i in volume depletion) — stop drug; volume optimise; consider alternatives[1]

First-line treatment

Interventions

  • Resuscitation and source control[1]
    Identify and treat precipitating cause: sepsis (early antibiotics + source control), volume depletion (crystalloid), cardiogenic shock (inotropes), nephrotoxin removal
  • Volume optimisation[1]
    Crystalloid (balanced solution preferred over 0.9% saline in non-traumatic AKI per BaSICS/PLUS); avoid synthetic colloids; assess volume status repeatedly — over-resuscitation causes congestion-induced AKI
  • Avoid further nephrotoxins[1]
    Stop NSAIDs, ACE-i/ARB if hypotensive, aminoglycosides, vancomycin (where alternative possible), iodinated contrast where deferable. Dose-adjust all drugs per current eGFR (assume GFR ~10 in oligo-anuric AKI)
  • Renal replacement therapy (RRT)[1]
    Indications (AEIOU): refractory Acidosis, Electrolytes (hyperkalaemia, hypercalcaemia), Intoxication (e.g., toxic alcohols, salicylates, lithium), Overload (refractory pulmonary oedema), Uraemic complications (encephalopathy, pericarditis). Earlier vs later initiation neutral in stable patients (STARRT-AKI)

First-line drug therapy

DrugClassAdultPaediatricNotes
Hyperkalaemia management[1]Acute potassium-lowering bundleCalcium gluconate 10% 10 mL IV slow push (cardiac membrane stabilisation if ECG changes); insulin 10 U + dextrose 50 mL of 50% IV; salbutamol 10–20 mg nebulised; bicarbonate 50–100 mmol IV if acidaemic; sodium polystyrene sulfonate (Kayexalate) 15–60 g PO/PRPer weight per paediatric guidelinesDefinitive treatment is RRT if refractory or recurrent
Loop diuretic (furosemide)[1]Loop diuretic40 mg IV bolus then titrate; furosemide stress test (1 mg/kg) predicts progression to RRT1 mg/kg IVSymptomatic fluid overload only; does NOT change AKI trajectory or mortality; do not give for oliguria alone
Hyperkalaemia management[1]
Acute potassium-lowering bundle
Adult
Calcium gluconate 10% 10 mL IV slow push (cardiac membrane stabilisation if ECG changes); insulin 10 U + dextrose 50 mL of 50% IV; salbutamol 10–20 mg nebulised; bicarbonate 50–100 mmol IV if acidaemic; sodium polystyrene sulfonate (Kayexalate) 15–60 g PO/PR
Paediatric
Per weight per paediatric guidelines
Definitive treatment is RRT if refractory or recurrent
Loop diuretic (furosemide)[1]
Loop diuretic
Adult
40 mg IV bolus then titrate; furosemide stress test (1 mg/kg) predicts progression to RRT
Paediatric
1 mg/kg IV
Symptomatic fluid overload only; does NOT change AKI trajectory or mortality; do not give for oliguria alone

Safety-net

  1. Maintain hydration but avoid over-drinking; track urine output and fluid balance daily during illness[1]
  2. Stop NSAIDs, ACE-i, ARBs, and SGLT2 inhibitors during acute illness with vomiting, diarrhoea, or fever — they can worsen AKI; restart only when stable[1]
  3. Recovery may take days to weeks; some patients have residual CKD — follow up creatinine and ACR after discharge[1]

Referral criteria

  • AKI Stage 3 OR refractory hyperkalaemia OR pulmonary oedemaICU and nephrology for RRT[1]
  • Suspected glomerulonephritis (haematuria, dysmorphic RBCs, proteinuria, RBC casts)Nephrology for urgent biopsy and immunosuppression decision[1]
  • Post-renal obstruction (hydronephrosis on US)Urology for catheterisation or nephrostomy[1]
  • AKI not recovering at 7 daysNephrology[1]

Clinical summary

Diagnosis, staging, and management of AKI per KDIGO criteria with bundle-based care for prevention, source control, and renal replacement decisions.

References

  1. 1.KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury (current; 2024 KDIGO CKD update for ongoing CKD-AKI overlap) (2012)

On this page

  • Red flags
  • First-line treatment
  • Safety-net
  • Referral
  • References